Full Text View
Tabular View
No Study Results Posted
Related Studies
Cardiovascular Protective Effect of Spironolactone in Hemodialysis
This study is currently recruiting participants.
Study NCT00277693   Information provided by Universidad Los Andes
First Received: January 12, 2006   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hemodialysis
Interventions listed in this trial
Spironolactone (drug)
Additional drug interventions recognized in this trial
Aldosterone Antagonists
Spironolactone
More general drug interventions related to this trial
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Universidad Los Andes


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services